$22 Million
For those who thought this is a about politics, it's not. $22 million is the amount it would take to bring a life-saving drug to market. Unfortunately, the company that was developing the drug, has decided that it's not profitable enough to continue development. Here's the backstory. On Wednesday of last week, the Lad and I met with the head of the Cardiovascular Connective Tissue Group at Stanford Medical Center, Dr. David Liang. He, along with Mitchel Pariani and Jehan Shaukat spent several hours with Rob and me giving us the lowdown about many Vascular Ehlers-Danlos Syndrome (vEDS) history and prognosis. They were amazing in their compassion and their knowledge. It was encouraging. My objective for being there was to learn as much as I can and to find out where I can help. In particular, what's being done with research and how can I help. They told me, "Well if you know someone who is famous who has vEDS, that would help." Aytu, a bio-medical compa